ISDA

Entry Detail

PDB ID:

4LR6

Keywords:

TRANSCRIPTION REGULATOR/INHIBITOR

Title:

Structure of BRD4 bromodomain 1 with a 3-methyl-4-phenylisoxazol-5-amine fragment

Biological Source:

Source Organism:

Homo sapiens

Host Organism:

Escherichia coli

PDB Version:

Deposition Date:

2013-07-19

Release Date:

2013-08-07

Method Details:

Experimental Method:

X-RAY DIFFRACTION

Resolution:

1.29 Å

R-Value Free:

0.24

R-Value Work:

0.21

R-Value Observed:

0.21

Space Group:

P 21 21 21

Download Validation Report

Macromolecular Entities

Protein Blast

Polymer Type:polypeptide(L)
Description:Bromodomain-containing protein 4
Chain IDs:A
Chain Length:128
Number of Molecules:1
Biological Source:Homo sapiens

UniProt ID:O60885 Pfam ID:PF00439

Ligand Molecules

1XA

FMT

Primary Citation

Discovery, Design, and Optimization of Isoxazole Azepine BET Inhibitors.

Gehling, V.S, Hewitt, M.C, Vaswani, R.G, Leblanc, Y, Cote, A, Nasveschuk, C.G, Taylor, A.M, Harmange, J.C, Audia, J.E, Pardo, E, Joshi, S, Sandy, P, Mertz, J.A, Sims, R.J, Bergeron, L, Bryant, B.M, Bellon, S, Poy, F, Jayaram, H, Sankaranarayanan, R, Yellapantula, S, Bangalore Srinivasamurthy, N, Birudukota, S, Albrecht, B.K.Show

ACS Med Chem Lett 4 835 840 (2013)

PMID: 24900758 DOI: 10.1021/ml4001485

Abstact

The identification of a novel series of small molecule BET inhibitors is described. Using crystallographic binding modes of an amino-isoxazole fragment and known BET inhibitors, a structure-based drug design effort lead to a novel isoxazole azepine scaffold. This scaffold showed good potency in biochemical and cellular assays and oral activity in an in vivo model of BET inhibition.

Legend

Protein

Chemical

Disease

Primary Citation of related structures